The Discounted Cash Flow (DCF) valuation of Neurocrine Biosciences Inc (NBIX) is 117.96 USD. With the latest stock price at 131.60 USD, the upside of Neurocrine Biosciences Inc based on DCF is -10.4%.
Based on the latest price of 131.60 USD and our DCF valuation, Neurocrine Biosciences Inc (NBIX) is a sell. selling NBIX stocks now will result in a potential gain of 10.4%.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 9.6% | 8.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 78.45 - 281.30 | 117.96 |
| Upside | -40.4% - 113.8% | -10.4% |